SQNMF (Sequana Medical NV) ROCE %: 0.00% (As of Jun. 2025)


SQNMF Sequana Medical NV SQNMF
29 GF Score
Price $1.22
GF Value $0.48
! 12 Warning Signs
View Full Analysis

What is Sequana Medical NV ROCE %?

Sequana Medical NV SQNMF 29 ROCE % is 0.00% as of Jun. 2025. GuruFocus rates SQNMF with a GF Score™ of 29/100 and a GF Value™ of $0.48. The stock has 12 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sequana Medical NV's annualized ROCE % for the quarter that ended in Jun. 2025 was 0.00%.

Sequana Medical NV  (OTCPK:SQNMF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sequana Medical NV ROCE % Related Terms

Sequana Medical NV ROCE % Historical Data

* Premium members only.

The historical data trend for Sequana Medical NV's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sequana Medical NV ROCE % Chart

Sequana Medical NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -299.60 -276.29 -312.07 -5,016.50 0.00

Sequana Medical NV Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -257.63 -3,521.13 0.00 0.00 0.00
SQNMF
29GF Score
Sequana Medical NV SQNMF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sequana Medical NV ROCE % Calculation

Sequana Medical NV's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-43.704/( ( (11.015 - 21.228) + (10.413 - 55.718) )/ 2 )
=-43.704/( (-10.213+-45.305)/ 2 )
=-43.704/-27.759
=157.44 %

Sequana Medical NV's ROCE % of for the quarter that ended in Jun. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2025 )  (Q: Dec. 2024 )(Q: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2025 )  (Q: Dec. 2024 )(Q: Jun. 2025 )
=-12.434/( ( (10.413 - 55.718) + (16.806 - 60.157) )/ 2 )
=-12.434/( ( -45.305 + -43.351 )/ 2 )
=-12.434/-44.328
=0 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Sequana Medical NV (SQNMF) has a ROCE % of 0.00% as of Jun. 2025.
Is Sequana Medical NV's ROCE % too high?
Sequana Medical NV's current ROCE % is 0.00%. Overall, Sequana Medical NV has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Sequana Medical NV's ROCE % compare to ABT and SYK?
Sequana Medical NV's ROCE % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sequana Medical NV's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sequana Medical NV stock overvalued right now?
Sequana Medical NV (SQNMF) has a current ROCE % of 0.00%. The stock's GF Value™ is $0.48, compared to a current price of $1.22 — trading 154.2% above its estimated fair value. The current ROCE % is 0.00%. Sequana Medical NV's overall GF Score™ is 29/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Sequana Medical NV (SQNMF), the current ROCE % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sequana Medical NV (SQNMF) Overvalued in 2026?

Based on GuruFocus' analysis, Sequana Medical NV stock appears to be overvalued. The current stock price of $1.22 is trading 154.2% above its estimated GF Value™ of $0.48.

Key valuation signals for SQNMF:

  • ROCE %: 0.00%
  • GF Value™: $0.48 vs. price of $1.22 (154.2% above fair value)
  • GF Score™: 29/100 with 12 warning signs

No single metric tells the full story. See the SQNMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sequana Medical NV Business Description

Other Exchanges 2SE:GermanySEQUA:Belgium
Address Kortrijksesteenweg 1112, bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies. The company's geographical segments include Switzerland, Germany, the United Kingdom, France, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
29GF Score

Get the complete analysis for SQNMF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.22
Price
$0.48
GF Value